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Type I myosinThe actin cytoskeleton plays a central role in many important cellular processes such as cell polarization, cell
division and endocytosis. The dynamic changes to the actin cytoskeleton that accompany these processes are
regulated by actin-associated proteins Wiskott–Aldrich Syndrome Protein (WASP) (known as Las17p in
yeast) and WASP-Interacting Protein (WIP) (known as Vrp1p in yeast). Both yeast and human WASP bind to
and stimulate the Arp2/3 complex which in turn nucleates assembly of actin monomers into ﬁlaments at
polarized sites at the cortex. WASP–WIP interaction in yeast and humans are important for Arp2/3 complex
stimulation in vitro. It has been proposed that these interactions are also important for polarized actin
assembly in vivo. However, the redundancy of actin-associated proteins has made it difﬁcult to test this
hypothesis. We have identiﬁed two point mutations (L80T and H94L) in yeast WASP that in combination
abolish WASP–WIP interaction in yeast. We also identify an N-terminal fragment of Las17p (N-Las17p1–368)
able to interact with Vrp1p but not Arp2/3. Using these mutant and truncated forms of yeast WASP we
provide novel evidence that WASP interaction with WIP is more important than interaction with Arp2/3 for
polarized actin assembly and endocytosis in yeast.
© 2009 Elsevier B.V. All rights reserved.1. Introduction
The actin cytoskeleton plays a fundamental role in many cellular
processes including polarized exocytosis, endocytosis, cell division
and cell motility. Assembly of actin monomers into ﬁlaments (F-
actin) may provide mechanical force on membranes driving these
processes. In budding yeast (Saccharomyces cerevisiae), F-actin is
organized into cortical actin patches, actin cables and the actomyo-
sin ring [1–3] Actin patches are dynamic structures with a polarized
distribution that cluster into small emerging buds, are randomly
dispersed in the mother and large bud during mitosis, and cluster at
the bud neck during cell division [1]. Cortical actin patches have
been proposed to be sites of endocytosis [4]. Actin patches exhibit
both short range motility at the cortex and long-range movement
into the cytoplasm.
The branched actin ﬁlaments that comprise cortical actin patches
[5] are nucleated by the Arp2/3 complex, a highly conserved sevenGFP, green ﬂuorescent protein;
3, Src Homology 3; WA, WH2/
SP Homology 1; WH2, WASP
SP and Verprolin Homologous
65 6791 3856.
u).
ll rights reserved.subunit complex which nucleates actin ﬁlament assembly from
actin monomers [6]. The long-range movement of actin patches is
driven by Arp2/3-dependent F-actin assembly [7]. Like in verte-
brates, in S. cerevisiae cells, Arp2/3 is activated by several nucleation
promoting factors (NPFs) [8]. These include Las17p/Bee1p which is
the yeast homologue of mammalian Wiskott–Aldrich Syndrome
Protein (WASP) and the type I myosins Myo3p and Myo5p [9–16].
Vertebrate WASP is an actin-associated protein expressed in
hematopoietic cells and mutations in WASP cause immune-
deﬁciency due to actin cytoskeletal defects in lymphocytes [17].
WASP-related proteins (e.g. N-WASP and WAVEs) are also NPFs and
are expressed in other cell types [18].
Both vertebrate WASP and yeast Las17p exhibit a modular
structure with a WASP Homology 1 domain (WH1) in the N-
terminal region that binds WIP (Vrp1p in yeast) and a C-terminal
WH2 (WASP Homology 2) domain that binds actin monomers. Both
proteins also have an acidic domain (A) at the C-terminal which
binds to and activates Arp2/3 [18]. Las17p interacts with the C-
terminal region of Vrp1p in a manner analogous to the interaction
between WASP and WIP in vertebrates [11, 17, 19] and Las17p and
type I myosins function redundantly in the activation of the Arp2/3
complex [13]. Given the existence of other NPFs, it is not yet clear
whether the interaction of Las17p with Arp2/3 is essential in vivo.
Indeed other NPFs have been shown to act redundantly with Las17p
in activation of Arp2/3 [14–16].
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ortholog WIP do not interact with Arp2/3 but instead interact with
NPFs and actin monomers, e.g. Las17p and type I myosins. The WH2
domains of Vrp1p and WIP bind monomeric actin and the Vrp1p
WH2 domain is functionally redundant with the Las17p WH2
domain [13,16,20]. The WH2 domains are essential for Arp2/3
activation by Las17p and type I myosins and have been proposed to
provide actin monomers competent for assembly into ﬁlaments by
Arp2/3 [14,16]. The acidic domains (A) of either type I myosin
(Myo3p or Myo5p) in combination with the WH2 domain of Vrp1p
promote actin polymerization by activating the Arp2/3 complex
analogous to Las17p [9, 13, 14, 16]. It has been shown recently that
Vrp1p is recruited to cortical sites at least in part through
interaction with Las17p and that Vrp1p in turn recruits type I
myosins to the cortical sites prior to actin assembly at those sites
[14–16, 21, 22]. This suggests that Vrp1p interaction with NPFs may
play a role in recruitment of NPFs to cortical sites and determine the
site of nascent actin patch formation.
Deletion of LAS17 (las17Δ) results in Las17p-deﬁcient cells with
defects in bulk endocytosis (uptake of external materials by cells) and
actin patch polarization at both permissive (24 °C) and restrictive
temperature (37 °C) and a defect in growth at restrictive temperature
[10, 11, 23]. These defects arise despite the presence of type I myosins,
Myo3p and Myo5p each of which has an acidic domain (A)
functionally redundant with that of Las17p [9, 13, 15]. This suggests
that Las17p may possess important cellular roles in the actin
cytoskeleton independent of Arp2/3 activation. In contrast to the
phenotype observed upon deleting the entire LAS17 gene, deleting
only sequences encoding the WH2 or A domain of Las17p
(Las17pΔWA) does not cause strong phenotypes at either 24 °C or
30 °C [12]. This suggests that either interaction with or stimulation of
Arp2/3 is not essential in vivo, or that redundancy with other NPFs
renders the speciﬁc role of Las17p in Arp2/3 activation non-essential.
In addition to its role in binding and activating Arp2/3, Las17p plays a
role in recruitment of Vrp1p to the cortex [14, 16, 21, 22]. It is possible
that this role of Las17p (or other roles yet to be identiﬁed) is
responsible for the defects observed in las17Δ cells rather than the
loss of Arp2/3 activation per se.
We show here that an N-terminal Las17p fragment comprising
of residues 1–368 (N-Las17p1–368) that retains interaction with
Vrp1p but not Arp2/3 functionally replaces full-length Las17p in
growth; bulk endocytosis and actin patch polarization. We identify
two mutations in the WH1 domain of N-Las17p1–368 that perturb
Las17p–Vrp1p interaction and show that they reduce the ability of
N-Las17p1–368 and full-length Las17p to function at elevated
temperature.Fig. 1. Las17p domain structure and the constructs used. Schematics of Las17p and its deletio
region (PPPP, 185–527) and C-terminal WH2 and A domains (WA, 528–633). Truncated pro2. Materials and methods
2.1. Strains, plasmids, media and reagents
SD minimal medium and YPUAD rich medium were prepared as
described in Munn et al. [24]. Plasmid DNA was introduced into yeast
cells using a modiﬁcation of the lithium acetate protocol [24]. IDY19
(MATa his3 leu2 ura3 trp1 mfa2::FUS1:lacZ) and IDY223 (MATa his3
leu2 ura3 trp1 las17::LEU2) have been described in Naqvi et al. [11].
AMY88 (MATa his4 leu2 ura3 lys2 vrp1::KanMx bar1) has been
described in Thanabalu et al. [21]. Yeast strain PJ69-4A (MATa his3
leu2 ura3 trp1 gal4 gal80 met2::GAL7-lacZ GAL2-ADE2 LYS2::GAL1-
HIS3) [25] was used to test yeast two-hybrid interactions.
2.2. DNA techniques and plasmid construction
Standard DNA techniques were performed as described in
Sambrook et al. [26]. The LAS17 gene with the endogenous promoter
[11] was digested with HindIII and BamHI and sub-cloned into the
centromeric plasmid YCplac33 [27] to make pLAS17. pN-LAS17 (N-
Las17p1–368 expressed from the LAS17 promoter) was constructed by
digesting pLAS17 with HindIII and EcoRI, ﬁlling the ends with Klenow
enzyme and ligation to generate a stop codon (after a.a. 368). It was
used for constructing sub-clones and the mutant pN-LAS17TL
construct by PCR mutagenesis (Fig. 1).
2.3. Yeast two-hybrid assay
DNA encoding N-Las17p1–206 and N-Las17p207–368 were cloned in-
frame with GAL4AD in vector pACT2 (activation domain, AD) (Clontech,
PaloAlto, CA)DNAencoding C-Vrp1p364–817 andMyo5p (SH3) (a.a.1085–
1219) were cloned in-frame with GAL4BD in vector pAS2-1 (binding
domain, BD) (Clontech, Palo Alto, CA). The AD and BD plasmids were
sequentially transformed into PJ69-4A and the transformants were
selected on solid SD minimal medium lacking tryptophan and leucine.
The two-hybrid interactionswere then investigated by testing the growth
of the transformants on the samemedium lacking histidine+2mM3-AT
to detect the expression of the HIS3 interaction reporter.
2.4. In vivo protein binding assays
C-Vrp1p364–817-6His or Myo5p(SH3)-6His were expressed in
IDY223 or AMY88 cells also expressing GFP-tagged Las17p fragments.
The yeast strains were grown to exponential phase at 24 °C and
harvested. The cell pellet was resuspended in PBS (Phosphate Buffered
Saline) and lysed using a mini Bead Beater 8 (Biospec Products,n constructs. Las17p contains an N-terminal WH1 domain (WH1, 1–184), a proline-rich
teins used for functional studies or for pull-down assays are shown as black bars.
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centrifugation and the supernatant incubated with Ni2+-NTA agarose
beads for 1 h at 24 °C. The beadswere subsequently washed twicewith
1% Triton X-100 in PBS and twice with 10 mM imidazole in PBS. The
bound proteins were eluted by boiling the beads in SDS-PAGE loading
buffer and analyzed by SDS-PAGE and western blot.Fig. 2. N-Las17p1–368 functionally substitutes for full-length Las17p in growth and ﬂuid-pha
CEN plasmids expressing Las17p, N-Las17p1–368 or N-Las17p1–368TL . Each strain was streaked f
after 3 days. (b) Growth curve of las17Δ cells carrying empty vector or CEN plasmids expre
were diluted to an OD600 of 0.05 in fresh YPUADmedium and incubated at either 24 °C or 37
plasmids expressing Las17p, N-Las17p1–368 or N-Las17p1–368TL were grown in YPUAD to expon
uptake assay for 1 h at either 24 °C or 37 °C. Upper panels: FITC-ﬂuorescence optics to visu2.5. Western blot
Cell pellets (7 OD600 unit each) were resuspended in 240 μl
(1.85 N NaOH/1.06 M β-mercaptoethanol) and incubated on ice for
10 min. The protein was precipitated by the addition of an equal
volume of 20% TCA (TriChloro Acetic Acid) and incubation on ice forse endocytosis. (a) Growth at 24 °C and 37 °C of las17Δ cells harboring empty vector or
or single colonies on YPUAD agar, incubated at either 24 °C or 37 °C, and photographed
ssing Las17p, N-Las17p1–368 or N-Las17p1–368TL . Overnight YPUAD cultures of each strain
°C. OD600 was monitored at 1 h intervals. (c) las17Δ cells harboring empty vector, or CEN
ential phase at 24 °C, either left at 24 °C or shifted to 37 °C for 1 h, before carrying out LY
alize LY. Lower panels: DIC optics to visualize cell proﬁles. Bar, 5 μm.
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resuspended in 100 μl of SDS-PAGE loading buffer. The proteins were
resolved on a 10% SDS-PAGE gel, electroblotted onto nitrocellulose
membranes and probed with appropriate primary antibodies and
secondary antibodies conjugated to horseradish peroxidase (HRP)
and detected using a chemiluminescence kit from Pierce (Rockford,
Illinois). Bands were visualized by ﬂuorography using X-ray ﬁlm
(Kodak Company, Rochester, NY).
2.6. Visualization of F-actin
Yeast cells grown to exponential phase in YPUAD at 24 °C were
ﬁxed by direct addition of 3.7% formaldehyde (ﬁnal concentration) to
the culture. For actin patch polarization at 37 °C the cells were shifted
to 37 °C for 2 h before ﬁxing. Fixed cells were washed once with PBS
before being permeabilized using 1% Triton X-100 in PBS. The
permeabilized cells were stained with Alexa-488-conjugated phalloi-
din (0.3 U) and analyzed by ﬂuorescence microscopy [28].
2.7. Fluid-phase endocytosis
To visualize ﬂuid-phase endocytosis, yeast cells growing exponen-
tially in YPUAD at 24 °C. The cells were then harvested and
preincubated at 24 °C or 37 °C for 1 h before being incubated in fresh
YPUAD containing LY (5 mg/ml) for 1 h at the same temperature. The
cells were then washed 3 times with ice-cold PBS containing 10 mM
NaN3, 10 mM NaF and visualized using ﬂuorescence microscopy [29].
2.8. Fluorescence microscopy
Cells growing exponentially at 24 °C in YPUAD were harvested,
washed once with PBS and the cell suspension was applied to a
microscope slide. Fluorescence was visualized by ﬂuorescence micro-Fig. 3. N-Las17p1–368 functionally substitutes for full-length Las17p in actin patch polariza
expressing Las17p, N-Las17p1–368 or N-Las17p1–368TL or 2 μmplasmids expressing either N-Las1
were visualized as described in Materials and methods. Bar, 5 μm. (b) Wild type (WT) or la
expressing Las17p, N-Las17p1–368 or N-Las17p1–368TL or 2 μm plasmid expressing either N-Las1
were visualized as described inMaterials and methods. 100 small budded cells were analyzed
otherwise. The experiment was repeated three times with similar results.scopy using a Leica DMRA2 microscope (Leica, Singapore) and images
captured using a CoolSNAPHQ camera (Roper Scientiﬁc, Trenton, NJ).
3. Results
3.1. An N-terminal Las17p fragment (N-Las17p1–368) functionally
replaces full-length Las17p in growth, actin cytoskeleton polarization
and bulk endocytosis
It is not known which of the various Las17p domains (Fig. 1) is
important for growth at elevated temperature. To determine the
minimal sequences of Las17p sufﬁcient to support growth at elevated
temperature, we tested the ability of centromeric plasmids expressing
truncated Las17p proteins (under the transcriptional control of the
LAS17 promoter) (Fig. 1) to restore growth at 37 °C to Las17p-deﬁcient
(las17Δ) cells (Fig. 2).
The results revealed that an N-terminal Las17p fragment (N-
Las17p1–368) that interacts with Vrp1p (Fig. 1) restores the viability of
las17Δ cells at 37 °C on solid and in liquid media (Fig. 2a, B). This
Las17p fragment was also able to restore ﬂuid-phase endocytosis and
a polarized distribution of actin patches to las17Δ cells at both 24 °C
and 37 °C (Fig. 2c, 3a, b). That N-Las17p1–368 is able to correct the actin
cytoskeletal defects of las17Δ cells was further supported by the
observation that the sensitivity of las17Δ cells to 1 M salt was
corrected by expression of N-Las17p1–368 (data not shown). Hence, the
Vrp1p-interacting domain of Las17p is sufﬁcient to functionally
substitute for full-length Las17p in vivo.
In order to determine the localization of Las17p and N-Las17p1–368,
we fused DNA sequences encoding green ﬂuorescent protein (GFP) to
the 3′ end of sequences encoding either full-length Las17p or N-
Las17p1–368. Both Las17p-GFP and N-Las17p1–368-GFP fusion proteins
expressed under the transcriptional control of LAS17 promoter
rescued the growth defects of las17Δ cells (data not shown). Livetion. (a) las17Δ cells harboring empty vector, or las17Δ cells harboring CEN plasmids
7p1–368 or N-Las17p1–368TL were grown in YPUAD and the actin patches at 24 °C and 37 °C
s17Δ cells harboring vector alone or las17Δ cells harboring centromeric (CEN) plasmids
7p1–368 or N-Las17p1–368TL were grown in YPUAD and the actin patches at 24 °C and 37 °C
and scored as polarized if the mother has less than 5 patches and scored as depolarized
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localized to cortical patches (Fig. 4a) and N-Las17p1–368-GFP also
localized to cortical patches in las17Δ cells at both 24 °C and 37 °C (Fig.
4a). In contrast, GFP alone showed a diffuse cytoplasmic distribution.
In order to determine whether N-Las17p1–368-GFP is localised to
cortical actin patches, we expressed Arc40-RFP (Red Fluorescent
Protein) in cells also expressing Las17p-GFP or N-Las17p1–368-GFP.
Arc40p is one subunit of Arp2/3 and is a known marker for cortical
actin patches [30]. Both Las17p-GFP and N-Las17p1–368-GFP patches
were found to partially (∼30%) co-localize with Arc40-RFP/cortical
actin patches (Fig. 4b).
3.2. Isolation of a mutation in N-Las17p1–368 that abolishes function in
growth
In order to characterize the function of N-Las17p1–368, at 37 °C, we
sought mutations that compromised N-Las17p1–368 function at 37 °C.Fig. 4.N-Las17p1–368 retains the ability to localize to cortical actinpatches. (a) las17Δ cells expres
fromCENplasmidswere grown inYPUAD to exponential phase at 24 °C and either left at 24 °Cor
panels: GFP. Lower panels: DIC optics Bar, 5 μm. (b) las17Δ cells co-expressing Arc40-RFP an
exponential phase at 24 °C. Both GFP and RFP were visualized in living cells by ﬂuorescence m
panels: GFP. Lower panels: RFP. Bar, 5 μm.We performed PCR mutagenesis on a DNA fragment encoding N-
Las17p1–368, expressed the mutated sequences in las17Δ cells, and
screened for the loss of the ability to restore growth at 37 °C. We
subsequently screened the mutants' ability to restore ﬂuid-phase
endocytosis and to correct the actin patch polarization defect of
las17Δ cells at 24 °C to ensure that the mutation does not abolish
function at 24 °C. We identiﬁed one mutant that fulﬁlled this criteria
and it had two amino acid substitutions L80T and H94L, thus labeled
as N-Las17p1–368TL . N-Las17p1–368 with either single mutation (N-
Las17p1–368T or N-Las17p1–368L ) was able to rescue the growth defects of
las17Δ (data not shown), thus both mutations are required to
compromise the activity of N-Las17p1–368.
Although expression of N-Las17p1–368TL does not rescue the growth
defect of las17Δ cell, it did restore ﬂuid-phase endocytosis and
polarization of actin patches at 24 °C. However, neither of these
defects was rescued at 37 °C (Figs. 2c, 3a, b).Western blot analysis was
performed to assess the level of expression of the wild type andsing greenﬂuorescent protein (GFP), Las17p-GFP, N-Las17p1–368-GFPorN-Las17p1–368TL -GFP
shifted to 37 °C for 2 h.GFPwas visualized in living cells by ﬂuorescencemicroscopy. Upper
d either Las17p-GFP, N-Las17p1–368-GFP or N-Las17p1–368TL -GFP were grown in YPUAD to
icroscopy. Arrows point to patches where Arc40p-RFP and Las17p-GFP co-localize. Upper
68
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Las17p1–368TL is expressed at levels comparable to that of wild type N-
Las17p1–368 at 24 °C, however upon shifting the cells to 37 °C for 2 h,
N-Las17p1–368TL became undetectable (Fig. 5b). N-Las17p1–368TL -GFP
localized to cortical actin patches at both 24 °C and 37 °C (Fig. 4a, b).
However there were fewer N-Las17p1–368TL -GFP patches at 37 °C
compared to 24 °C, suggesting that the loss of activity at 37 °C
could be due to reduced level of the mutant protein. In order to test
whether the loss of activity at 37 °C is due to poor expression of the
mutant protein at 37 °C we expressed both N-Las17p1–368 and N-
Las17p1–368TL from 2 μm (high-copy number) plasmids. Under these
conditions N-Las17p1–368TL levels approached those of N-Las17p1–368
even after 2 h at 37 °C (Fig. 5b). Expression of N-Las17p1–368TL from a
2 μm plasmid rescued the growth defect of las17Δ at 37 °C (Fig. 5a)
without correcting the actin patch polarization defect at 37 °C (Fig.
3a, b). Over-expression of N-Las17p1–368TL froma2 μmplasmiddoesnot
perturb the actin cytoskeleton in wild type yeast cells (Fig. S1a, b).
Hence, while loss of function (growth and endocytosis) of N-Las17p1–3TL
at 37 °C when expressed from CEN plasmid may be due to reduced
protein level (as evidenced by rescue when the mutated fragment is
over-expressed from a 2 μm plasmid) such reduced expression cannot
account for the observed loss of actin patch polarization at 37 °C.
3.3. L80T H94L mutations in N-Las17p1–368 affect binding to Vrp1p
The reduced expression of N-Las17p1–368TL at 37 °C may be due to
protein instability caused by loss of interaction with other key
cytoskeletal regulators. Las17p has been shown to interact with many
cytoskeletal proteins including actin, Vrp1p, Bzz1p, Myo3p, Myo5p and
Rvs167p [11, 13, 15, 31–33]. Residues 20–122 of Las17p mediate
interaction with Vrp1p [13]. Since the L80T H94L mutations fall in this
region of the protein, we ﬁrst examined the interaction of N-Las17p1–368Fig. 5. Loss of function in growth due to the L80T H94L mutations is due to reduced stea
centromeric (CEN) plasmids expressing N-Las17p1–368 or N-Las17p1–368TL or a 2 μm plasmid
incubated at either 24 °C or 37 °C, and photographed after 3 days. (b) Steady-state expre
expressing N-Las17p1–368-GFP, N-Las17p1–368TL -GFP, Las17p-GFP or Las17pTL-GFP from low (l
YPUAD to exponential phase at 24 °C and either left at 24 °C or shifted to 37 °C for 2 h. Protein
serum as described in Materials and methods.and N-Las17p1–368TL (each tagged with GFP) with the C-terminal Las17p
binding domain of Vrp1p (C-Vrp1p364–817) (tagged with 6His) in vivo
using co-precipitation at 24 °C (Fig. 6a). While N-Las17p1–368-GFP
interacted with C-Vrp1p364–817-6His, N-Las17p1–368TL did not interact
with C-Vrp1p364–817-6His (Fig. 6a). We were unable to determine the
interaction at 37 °C due to degradation of the mutant proteins at 37 °C
(data not shown). Interaction of N-Las17p1–368 with C-Vrp1p364–817 was
also tested in a yeast two-hybrid assay and the L80T H94L mutations in
N-Las17p1–368 abolished interaction with C-Vrp1p364–817 (data not
shown). We have previously shown that C-Vrp1p364–817-GFP does not
localize to cortical patches in las17Δ strain [21].Weused this observation
to test the interaction between C-Vrp1p364–817-GFP andN-Las17p1–368 in
las17Δ strain. C-Vrp1p364–817-GFP expressed from a CEN plasmid
localized to cortical patches at both 24 °C and 37 °C in the presence of
N-Las17p1–368 expressed from either CEN (data not shown) or 2 μm
plasmid (Fig. S2) but not in the presence of N-Las17p1–368TL expressed
from CEN (data not shown) or 2 μm plasmid at both 24 °C and 37 °C
(Fig. S2). Together, these data suggest that the interaction between
N-Las17p1–368 and C-Vrp1p364–817 is abolished by the L80T H94L
mutations. The L80T H94L mutations did not perturb interaction of N-
Las17p1–368 with a panel of other actin cytoskeletal proteins including
Hof1p, Bzz1p and Rvs167p based on yeast two-hybrid assay (data not
shown). This suggests that N-Las17p1–368TL loss of function and reduced
state level is most likely due to speciﬁc loss of interaction with Vrp1p.
3.4. Vrp1p promotes the formation of a Las17p/Vrp1p/Myo5p complex
Type I myosins, Myo3p and Myo5p can interact with Las17p via
direct binding of their SH3 domains with proline-rich motifs in
Las17p or indirectly via other proteins [13, 15]. Therefore, we
examined the interaction of N-Las17p1–368-GFP and N-Las17p1–368TL -
GFP with the SH3 domain of Myo5p (a.a. 1085–1219) (tagged withdy-state protein expression. (a) Growth at 24 °C and 37 °C of las17Δ cells harboring
expressing N-Las17p1–368TL . Each strain was streaked for single colonies on YPUAD agar,
ssion levels of wild type and mutant Las17p proteins. las17Δ cells harboring plasmids
eft, CEN plasmid) or high (right, 2 μm plasmid) copy number plasmids were grown in
extract was isolated and analyzed using anti-GFP (α-GFP) and anti-hexokinase (α-Hex)
Fig. 6. The L80T and H94L mutations in Las17p abolish interaction with Vrp1p. The Las17p-GFP fusion proteins and Vrp1p-6His-tagged proteins (as indicated below) were co-
expressed from the endogenous promoters on low-copy number (CEN) plasmids in either vrp1Δ cells (a) or las17Δ cells (b) and the 6His-tag was used to pull down the 6His-
tagged protein and its associated proteins from total cell lysates at 24 °C with beads as described in Materials and methods. Bound proteins were eluted from the beads and
resolved by SDS-PAGE and analyzed by Western blot using anti-GFP (α-GFP) serum and anti-His (α-His) serum. (a) Analysis of Vrp1p–Las17p interaction by pull-down assays.
vrp1Δ cells expressing C-Vrp1p364–817-6His in combination with either GFP only, N-Las17p1–368-GFP, N-Las17p1–368TL -GFP or N-Las17p1–206-GFP. (I) Western blot of the proteins
eluted from beads following incubation of beads with cleared lysate. (II) Western blot of total cleared lysate before incubation with beads. (b) Analysis of Las17p–Myo5p
interactions by pull-down assays. las17Δ cells expressing Myo5p(SH3)-6His in combination with either GFP only, N-Las17p1–368-GFP, N-Las17p1–368TL -GFP or N-Las17p1–206-GFP. (I)
Western blot of the proteins eluted from Ni2+-NTA-Agarose beads following incubation of beads with cleared lysate. (II) Western blot of total lysate cleared before incubation with
beads. (c) Yeast two-hybrid analysis of Vrp1p–Las17p and Las17p–Myo5p interactions. pACT2 (activation domain) plasmids expressing N-Las17p1–206, N-Las17p207–368 or empty
vector were tested for two-hybrid interactionwith pBD (DNA binding domain) plasmids expressing C-Vrp1p364–817 (C-Vrp1p) orMyo5p(SH3) or empty vector in two-hybrid reporter
strain PJ69-4A. Two-hybrid interaction activates expression of the HIS3 reporter gene and was scored by growth on selective media lacking histidine (+2 mM 3-aminotriazole).
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down from yeast cell lysates with Myo5p-SH3-6His (Fig. 6b).
However, the N-Las17p1–368-GFP band was more intense than the
N-Las17p1–368TL -GFP band, suggesting that more molecules of N-
Las17p1–368-GFP are in complex with the Myo5p-SH3 domain than
the mutant N-Las17p1–368TL -GFP. This could be due to association of
N-Las17p1–368-GFP with Vrp1p as Vrp1p has multiple predicted
Myo5p SH3 binding sites [15]. In order to test whether direct
interaction with Myo5p was affected by the L80T H94L mutations,
we made two constructs, N-Las17p1–206-GFP which includes the
Vrp1p binding region but lacks the Myo5p-SH3 binding motifs and
N-Las17p207–368-GFP which conversely includes the region rich in
Myo5p-SH3 binding motifs but lacks the Vrp1p binding region. The
interaction of N-Las17p1–206 (tagged with GFP) with C-Vrp1p364–817
or Myo5p-SH3 (each tagged with 6His) in vivo was examined in a
pull-down assay (Fig. 6a, b). N-Las17p1–206-GFP interacted strongly
with both C-Vrp1p364–817 and Myo5p-SH3 in the pull-down assay
consistent with the possibility that N-Las17p1–206 pulls down with
Myo5p-SH3 due to formation of a complex with Vrp1p and that theN-Las17p1–206–Myo5p-SH3 interaction is indirect and mediated by
Vrp1p. The N-Las17p207–368-GFP was very unstable thus we could not
carry out the pull-down assay (data not shown). The interactions of
N-Las17p1–206 and N-Las17p207–368 with C-Vrp1p364–817 and Myo5p-
SH3, was also examined in a yeast two-hybrid assay. The yeast two-
hybrid assay showed that N-Las17p207–368 interacts with Myo5p-SH3
but not C-Vrp1p364–817 (Fig. 6c). Conversely, N-Las17p1–206 interacts
with C-Vrp1p364–817, but not Myo5p-SH3 (Fig. 6c). Thus, the Las17p
region affected by the L80T H94L mutations appears to speciﬁcally
mediate binding to Vrp1p.
3.5. The L80T H94L mutations do not abolish the function of full-length
Las17p
We next analyzed how the L80T H94L mutations affect the
function of full-length Las17p which has the Arp2/3 activating WA
domains. Expression of Las17pTL in las17Δ cells restored ﬂuid-phase
endocytosis at both 24 °C and 37 °C and also corrected the growth
defects at 37 °C (Fig. 7a–c). Las17pTL was also able to restore actin
Fig. 7. Vrp1p–Las17p interaction is functionally redundant with Las17p–Arp2/3 interaction for growth at elevated temperature and endocytosis. (a) The Las17p L80T H94L mutations
do not affect growth or colony formation on solid media. Growth at 24 °C and 37 °C of las17Δ cells expressing Las17p or Las17pTL from the endogenous LAS17 promoter on low-copy-
number (CEN) plasmids or harboring empty vector. Each strain was streaked for single colonies on YPUAD agar, incubated at 24 °C or 37 °C and photographed after 3 days. (b) The
Las17p L80T H94L mutations do not affect doubling time in liquid culture. Growth curve of las17Δ cells harboring low-copy-number (CEN) plasmids expressing Las17p or Las17pTL
from LAS17 promoter or empty vector. (c) The L80T H94L mutations do not abolish the endocytic function of full-length Las17p. las17Δ cells expressing wild type Las17p or mutant
Las17pTL from the LAS17 promoter on low-copy-number (CEN) plasmids or harboring empty vector were grown in YPUAD were assayed for LY uptake as described in Materials and
methods. Upper panels: LY. Lower panels: DIC optics. Bar, 5 μm. (d) The L80T and H94L mutations in Las17p abolish interaction with Vrp1p. Total (cleared) extracts from las17Δ cells
co-expressing C-Vrp1p364–817-6His from the VRP1 promoter and either expressing Las17p-GFP or Las17pTL-GFP from the LAS17 promoter on low-copy-number (CEN) plasmids were
incubated with Ni2+-NTA agarose beads, processed and analysed as described in Fig. 6a. (I) Western blot of the proteins eluted from beads following incubation of beads with cleared
lysate. (II) Western blot of total (cleared) lysate before incubation with beads.
832 R. Rajmohan et al. / Biochimica et Biophysica Acta 1793 (2009) 825–835patch polarization to las17Δ cells at 24 °C (Fig. 8a, b). Las17pTL was not
able to fully restore actin patch polarization at 37 °C (Fig. 8a, b).
We analyzed the localization and expression of Las17pTL using
Las17pTL-GFP. The presence of the L80T H94L mutations did not affect
the localization of Las17pTL-GFP to cortical patches in las17Δ cells at
24 °C or 37 °C (Fig. S3). Western blotting of cell extracts from las17Δ
cells expressing Las17p-GFP or Las17pTL-GFP showed that the
expression of Las17pTL was similar to that of Las17p at 24 °C but the
expression of Las17pTL at 37 °C was reduced compared to Las17p (Fig.
5b). Thus we also analyzed the ability of Las17pTL over-expressed froma 2 μm plasmid to rescue actin patch polarization at 37 °C (Fig. 8a, b).
The Las17pTL expressed from 2 μm plasmid did not rescue the actin
patch defect at 37 °C. Hence the L80T H94L mutations abolish actin
patch polarization at 37 °C but not at 24 °C and do not abolish growth
at 37 °C. Over-expression of Las17p and Las17pTL does not perturb the
actin cytoskeleton in wild type yeast cells (Fig. S1a, b).
We next examined if these mutations in Las17pTL affect Las17p
interaction with Vrp1p. This was assessed by testing the binding of
Las17p or Las17pTL (each tagged with GFP) in yeast cell lysate with C-
Vrp1p364–817 (tagged with 6His) in a pull-down assay. Las17p-GFP
Fig. 8. Vrp1p–Las17p interaction is critical for actin patch polarization at 37 °C. (a) The Las17p L80T H94L mutations perturb actin patch polarization only at 37 °C. las17Δ cells
expressing Las17p or Las17pTL from the LAS17 promoter from either low-copy-number (CEN) plasmids or a 2 μm plasmid or a harboring empty vector were grown in YPUAD to
exponential phase at 24 °C and either left at 24 °C (upper panel) or shifted to 37 °C for 2 h (lower panel). Bar, 5 μm. (b)Wild type (WT) or las17Δ cells harboring vector alone or las17Δ
cells expressing Las17p or Las17pTL from the LAS17 promoter from either low-copy-number (CEN) plasmids or a 2 μm plasmid were grown in YPUAD to exponential phase at 24 °C
and either left at 24 °C or shifted to 37 °C for 2 h and analysed as described in Fig. 3b.
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this interaction (Fig. 7d). Loss of interaction of Las17p with Vrp1p
maybe a possible reason why the L80T H94L mutations result in
lowered Las17p stability and abolish actin patch polarization at 37 °C.
Thus, the binding of Las17p to Vrp1p is not necessary for function at
24 °C but becomes essential at 37 °C for protein stability and actin
patch polarization.
In order to address the role of the proline sequences (a.a. 207–368)
in N-Las17p we expressed the N-Las17p1–206 in las17Δ cells under the
transcriptional regulation of LAS17 promoter from a cen plasmid. The
results revealed that an N-terminal Las17p fragment (N-Las17p1–206)
that interacts with Vrp1p but lacks both the proline-rich sequences
and WA domain required for interaction with Arp2/3 (Fig. 1) restores
the viability of las17Δ cells at 37 °C (Fig. 9a). This Las17p fragment was
also able to localize to cortical patches (Fig. S3), restore ﬂuid-phase
endocytosis and a polarized distribution of actin patches to las17Δ
cells at 24 °C but not 37 °C (Fig. 9b, c).
4. Discussion
In this study, we have shown that expression of an N-terminal
fragment of Las17p that interacts with Vrp1p but not Arp2/3 (N-
Las17p1–368) is sufﬁcient to restore ﬂuid-phase endocytosis, actin
patch polarization and growth at 37 °C to las17Δ cells. We screened
for and isolated an N-Las17p1–368 mutant, (N-Las17p1–368TL ) which
abolished the interaction between Las17p and Vrp1p. N-Las17p1–368
with the mutation (N-Las17p1–368TL ) retains the ability to rescue the
ﬂuid-phase endocytosis and actin patch polarization defects of
las17Δ cells at 24 °C, but loses this ability at 37 °C. Expression of N-
Las17p1–368TL using 2 μm plasmid rescued the growth and ﬂuid-phase
endocytosis defect of las17Δ at 37 °C but not the actin patch
polarization defect of las17Δ at 37 °C. Similarly the mutation
abolished the ability of full-length Las17p to rescue the actin patch
polarization defect at 37 °C even when expressed from a 2 μm
plasmid. Thus Las17p–Vrp1p interaction is not critical for growth at
elevated temperature or ﬂuid-phase endocytosis or actin patchpolarization at 24 °C. However Las17p–Vrp1p interaction is essential
for polarization of actin patches at 37 °C.
The amino acid residues L80 and H94mutated in N-Las17p1–368TL are
located within the WH1 domain of Las17p (Fig. 1). These amino acid
residues are conserved in the WH1 domain of mammalian WASP, the
corresponding residues in human WASP being L101 and H115 which
lies in the region of WASP 101–150 which mediates interaction with
WIP [17]. Mutation of H115 to Y in humanWASP leads to a severe form
of Wiskott–Aldrich Syndrome [34]. Several of the mutations in WASP
which cause the disease have been shown to abolish WASP–WIP
interaction [17], suggesting that mutations in the WH1 domain of
WASP affect function by abolishing the interaction with WIP, the
human homologue of yeast Vrp1p. Consistent with an important role
for WASP–WIP interaction we have previously found that expression
of human haematopoietic WASP is able to correct the growth defects
of las17Δ cells if human WIP is co-expressed. Mutations in human
WASP that abolish WASP–WIP interaction also abolished the ability of
humanWASP to correct growth defects of las17Δ cells in the presence
of human WIP [35].
How does N-Las17p1–368 without the Arp2/3 activating domain
(WA) rescue all the defects of las17Δ cells? This may be because N-
Las17p1–368 is present in a complex with other proteins that have an
Arp2/3 activating domain of their own (e.g. type I myosins, Myo3 and
Myo5). Las17p has 4 predicted type I myosin SH3 domain binding
motifs compared to 17 such motifs in Vrp1p [15]. Both N-Las17p1–368
and N-Las17p1–368TL form complexes with Myo5p, the wild type N-
Las17p1–368 was found to be in a complex with more molecules of
Myo5p than the mutant N-Las17p1–368TL (Fig. 6) consistent with the
ability of N-Las17p1–368 but not N-Las17p1–368TL to interact with Vrp1p.
Thus, N-Las17p1–368TL forms a complex with Myo5p only through direct
binding. In contrast, the wild type N-Las17p1–368 can form a complex
with Myo5p both through direct binding as well as indirectly through
its interaction with Vrp1p. The increased amount of type I myosin in
the N-Las17p1–368 complex may enhance N-Las17p1–368 stability and
its ability to rescue the growth defects as well as bulk endocytosis and
actin patch polarization at 37 °C compared to N-Las17p1–368TL . We
Fig. 9. N-Las17p1–206 functionally substitutes for full-length Las17p in growth at 37 °C; ﬂuid-phase endocytosis and actin patch polarization at 24 °C. (a) Growth at 24 °C and 37 °C of
las17Δ cells harboring empty vector or CEN plasmids expressing N-Las17p1–368 or N-Las17p1–206. Each strainwas streaked for single colonies on YPUAD agar, incubated at either 24 °C
or 37 °C, and photographed after 3 days. (b) las17Δ cells harboring empty vector, or CEN plasmids expressing N-Las17p1–368 or N-Las17p1–206 were grown in YPUAD were used to
carry out LYuptake assay as described inMaterials andmethods. Upper panels: FITC-ﬂuorescence optics to visualize LY. Lower panels: DIC optics to visualize cell proﬁles. Bar, 5 μm. (c)
las17Δ cells harboring empty vector, or CEN plasmids expressing N-Las17p1–368 or N-Las17p1–206 were grown in YPUAD and the actin patches at 24 °C and 37 °C were visualized as
described in Materials and methods. Bar, 5 μm.
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cells by stabilizing Vrp1p protein levels but could not detect any
enhanced stability of Vrp1p-GFP in the presence of N-Las17p1–368
compared to N-Las17p1–368TL even at 37 °C (data not shown). Hence, we
believe that it is the physical interaction itself that is important for
Las17p, Vrp1p and type I myosin function.
The differential requirement for Vrp1p interaction at 37 °C
compared to 24 °C suggests that a complex containing N-Las17p1–368
and type I myosin may have enough NPF activity to restore bulk
endocytosis and actin patch polarization at 24 °C but to perform these
functions at 37 °C, the complex needs to also contain Vrp1p. The
proline-rich sequences between 207–368 in Las17p are essential for
actin patch polarization and endocytosis at 37 °C. Inclusion of Vrp1p in
the complex is predicted to increase the amount of type I myosins as
well as provide an additionalWH2domain and two other actin binding
domains to supply assembly-competent actin monomers [21, 22] for
nucleation of ﬁlament assembly by the Arp2/3. While advantageous
even at 24 °C, the extraNPF and actin-monomer-binding activitiesmaybecome necessary for function at 37 °C. The reduced steady-state
level of Las17p mutant proteins unable to bind Vrp1p at 37 °C
suggests that Vrp1p binding to the WH1 domain of Las17p may
stabilize Las17p in S. cerevisiae. Consistent with this, WIP binding to
the WH1 domain of WASP stabilizes WASP in mammalian cells as
well as in S. cerevisiae [35, 36]. Vrp1p may act as chaperone for
Las17p and this role becomes essential under the stress of high
temperature.
Our results highlight the functional conservation of theWASP–WIP
complex in humans and S. cerevisiae (Las17p–Vrp1p). In both
organisms the WIP (WIP or Vrp1p) stabilizes the respective WASP
(WASP or Las17p). In yeast Las17p has built in redundancy such that
loss of the WA domain does not lead to severe phenotypes probably
due to complex formation with type I myosins. In mammals the
WASP–WIP complex includes cortactin, a protein with an N-terminal
acidic domain and C-terminal SH3 domain but without aWH2 domain
[37,38]. Thus the interaction of cortactinwith theWASP–WIP complex
in humans may play a similar role to myosin I interaction with the
835R. Rajmohan et al. / Biochimica et Biophysica Acta 1793 (2009) 825–835Las17p–Vrp1p complex in S. cerevisiae. In humans mutations that
abolish WASP–WIP interaction lead to Wiskott–Aldrich Syndrome, a
disease with cytoskeletal abnormalities analogous to those that result
from loss of Las17p–Vrp1p interaction in S. cerevisiae. This suggests
that the interaction between WASP and WIP is crucial for WASP
functions and/or stability in yeast and humans.
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